Oxford–AstraZeneca COVID-19 vaccine

Bulgaria will order over 3 million additional doses of RNA vaccines. This was announced by Minister of Health Kostadin Angelov in the framework of today's government meeting. To this end, the government allocates extra BGN 9 million.

As announced by President Aleksandar Vui yesterday, it was ensured that a total of another 88.000 doses of Pfizer would arrive on February 15 and 22, 42.000 on the first occasion and 46.000 on the second.

Vui said that 50.000 doses of the Russian vaccine against the coronavirus Sputnik V arrived at the Belgrade airport this morning, and that more Pfizer vaccines and AstraZeneca vaccines will arrive by the end of February.

South Africa suspended the start of its AstraZeneca inoculation programme over concerns the shot does not work on a new variant, with WHO experts due to meet on Feb. 8 to discuss the vaccine already facing questions about its efficacy for over-65s.

Greece's National Vaccination Committee has unanimously approved the vaccine against the coronavirus produced by pharmaceuticals firm AstraZeneca for those aged 64 and younger.

More specifically, vaccinations for the 60-64 age group will start sometime after February 12, it was announced on Friday.

The online registration platform will open in the coming days.

Greece's National Vaccination Committee has unanimously approved the vaccine against the coronavirus produced by pharmaceuticals firm AstraZeneca, for those aged 64 and younger.

Vaccinations for the 60-64 age group will start sometime after February 12, it was announced Friday. The online registration platform will open in the coming days.

Greece's National Vaccination Committee is considering not giving the Oxford/AstraZeneca vaccine against Covid-19 to people older than 65, Kathimerini understands.

The Greek panel will announce it's decision either today of Thursday.

There is not enough data to say for sure "how well the AstraZeneca/Oxford vaccine would work" in people over 55, and the reason for this is that most of the participants in the manufacturer's preliminary studies are between 18 and 55 years old.

About 1,500 of the initial volunteers in a late-stage clinical trial of the Oxford/AstraZeneca COVID-19 vaccine were given the wrong dose, but weren't informed that a mistake had been made after the blunder was discovered, documents obtained by Reuters show.

The European Commission will continue discussions with AstraZeneca with the purpose of receiving more doses of its Covid-19 vaccine than the company has so far pledged in the first quarter of the year, a spokesman said on Monday.